# 2026-07907: White House fast-tracks psychedelics for serious mental health crises

2026-07907, Accelerating Medical Treatments for Serious Mental Illness, is a Federal Register presidential document from Executive Office of the President published 2026-04-22, effective 2026-04-18; PRIA reads it as touching household money (as of 2026-11-04).

- Canonical: https://policyrisk.com/federal-register/2026-07907
- As of: 2026-11-04
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-07907
- Title: Accelerating Medical Treatments for Serious Mental Illness
- Type: Presidential Document
- Agencies: Executive Office of the President
- Citation: 91 FR 21709
- Published: 2026-04-22
- Effective: 2026-04-18
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-11-04

## In one line

White House fast-tracks psychedelics for serious mental health crises

## Summary

Millions of Americans, including many veterans, struggle with serious mental illnesses that current treatments don’t fully fix. This new order speeds up research and approval of promising new therapies, like psychedelic drugs, to help those who haven’t found relief yet. The government is committing resources now to bring better treatments faster and save lives.

## Effects PRIA read

- Faster FDA Review for Psychedelic Drugs: benefit, medium. The FDA Commissioner will award Commissioner's National Priority Vouchers to appropriate psychedelic drugs that have received Breakthrough Therapy designation, speeding their review. This prioritization explicitly applies to psychedelic products meeting the National Priority Voucher Program criteri…
- Right-to-Try Access Pathway: benefit, high. The FDA and DEA must establish a pathway so eligible patients can access psychedelic drugs, including ibogaine compounds, under the federal Right to Try Act (21 U.S.C. 360bbb-0a). The agencies will also address any necessary Schedule I handling authorizations for treating physicians and researchers…
- $50M Federal Support for State Programs: benefit, medium. The Advanced Research Projects Agency for Health (ARPA-H) within HHS will allocate at least $50 million from existing funds to support and partner with State governments that have enacted or are developing programs to advance psychedelic drugs for serious mental illnesses. The funding can be used f…
- VA Collaboration to Boost Trials and Data: benefit, high. HHS and FDA will work with the Department of Veterans Affairs (VA) and, where appropriate, the private sector to increase clinical trial participation, data sharing, and real-world evidence around psychedelic drugs, prioritizing Breakthrough Therapy-designated drugs. HHS, FDA, and VA are directed t…
- Faster Rescheduling After Phase 3 Success: benefit, high. The Attorney General, in consultation with HHS, must review any product containing a Schedule I substance that has successfully completed Phase 3 clinical trials for a serious mental health disorder so that rescheduling (under 21 U.S.C. 811) may proceed as quickly as practicable for products ultima…

## Related documents

- [2026-22385](https://policyrisk.com/federal-register/2026-22385): Adjusting Imports of Robotics, Industrial Machinery, and Their Parts and Components Into the United States, 2026-11-02
- [2026-22292](https://policyrisk.com/federal-register/2026-22292): Further Modifying the Scope of Products of Canada Subject to the Additional Duties Imposed To Offset Canadian Discrimination Against the Co…, 2026-10-30
- [2026-22051](https://policyrisk.com/federal-register/2026-22051): Decreasing Housing Costs for the American People, 2026-10-28
- [2026-22052](https://policyrisk.com/federal-register/2026-22052): Presidential Determination Pursuant to Section 303 of the Defense Production Act of 1950, as Amended, on Domestic Petroleum Production, Ref…, 2026-10-28
- [2026-22049](https://policyrisk.com/federal-register/2026-22049): Adjusting Imports of Wind Turbines and Their Parts and Components Into the United States, 2026-10-28
- [2026-22050](https://policyrisk.com/federal-register/2026-22050): National Seafood Month, 2026, 2026-10-28

## Sources
- [2026-07907 on federalregister.gov](https://www.federalregister.gov/documents/2026/04/22/2026-07907/accelerating-medical-treatments-for-serious-mental-illness)
- [2026-07907 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-04-22/pdf/2026-07907.pdf)

## Related
- [Previous: 2026-07731, Authorizing Enbridge Pipelines (Southern Lights) L.L.C. To Operate and Maintain…](https://policyrisk.com/federal-register/2026-07731)
- [Next: 2026-08009, Presidential Determination Concerning the Air Force's Jet Fighter Training Oper…](https://policyrisk.com/federal-register/2026-08009)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-07907 (as of 2026-11-04).